The Latest Cardiac and Vascular News
LONDON, Jan. 31, 2018 /PRNewswire/ — The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other […]
This first of it’s kind trial compares two leading DCB technologies. Boston Scientific’s drug-coated balloon goes up against Medtronic’s DCB in first-of-its-kind trial JANUARY 31, 2018 BY SARAH FAULKNER, Drug Delivery Business NEws Top-line results from a head-to-head trial comparing Boston Scientific‘s (NYSE:BSX) Ranger drug-coated balloon and Medtronic‘s (NYSE:MDT) In.Pact Admiral DCB found no […]
PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ — Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical. Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is […]
Rouen, January 30, 2018 – Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology. This committee will help define the clinical strategy of the company and more […]
Medtronic Completes the Purchase of QT Vascular’s Chocolate PTA Balloon Catheter Highlights: – Medtronic completes the purchase of the Company’s non-drug coated Chocolate® PTA balloon catheter – The completion of this purchase validates the value of this internally developed specialty PTA to improve outcomes in patients with peripheral artery disease PLEASANTON, Calif., […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the FDA has approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with refractory angina (RA). The CardiAMP Chronic Myocardial Ischemia Trial will be […]
IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD DUBLIN and LEIPZIG – January 30, 2018 – Medtronic (NYSE: MDT) today added to its robust […]
MINNEAPOLIS, Jan. 29, 2018 /PRNewswire/ — Mardil Medical Inc., a privately held, clinical-stage medical device company, announced the appointment of Martin Madden to its Board of Directors. A 30-year veteran of Johnson & Johnson’s Research & Development division, Madden has unparalleled experience in bringing exceptional new products and technologies to the market. […]
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Greg Morrow as the Company’s Chief Marketing Officer, effective immediately. Mr. Morrow brings to Endologix a wealth of executive marketing experience in medical devices. Most recently, he led the Coronary […]
Novel Technology is Designed to Restore Blood Flow to Ischemic Lower Limbs, Which May Resolve Pain, Help Wounds Heal and Avoid Major Amputation PARIS–(BUSINESS WIRE)– LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), today announced completion of enrollment of the original 10-patient cohort in […]
